OTCMKTS:INVVY Indivior (INVVY) Stock Price, News & Analysis $21.85 -0.40 (-1.82%) As of 06/9/2023 Add Compare Share Share Stock Analysis Stock Analysis About Indivior Stock (OTCMKTS:INVVY) Get Indivior alerts:Sign Up Key Stats Today's Range$21.64▼$21.8550-Day Range$21.85▼$21.8552-Week Range$14.76▼$35.50Volume8,100 shsAverage Volume3,825 shsMarket Capitalization$3.01 billionP/E Ratio20.81Dividend YieldN/APrice Target$50.00Consensus RatingBuy Company Overview Indivior plc is a specialty pharmaceutical company focused on developing and commercializing treatments for substance-use disorders and other conditions affecting the brain. Its portfolio is centered on medications for opioid-use disorder, including SUBLOCADE, a once-monthly extended-release buprenorphine injection, and SUBOXONE, a buprenorphine and naloxone product available in sublingual formulations. The company also markets BRIXADI, an extended-release buprenorphine injection, and OPVEE, a nalmefene nasal spray designed to provide emergency treatment for known or suspected opioid overdose. Indivior also offers products in related behavioral-health areas, including PERSERIS, a long-acting injectable formulation of risperidone used to treat schizophrenia in adults. The company serves healthcare providers and patients primarily in the United States, while also operating and commercializing products in selected international markets. Indivior was established in 2014 after being separated from Reckitt Benckiser Group, which had acquired the business through its purchase of the pharmaceutical company formerly known as Reckitt Benckiser Pharmaceuticals. The company is headquartered in Richmond, Virginia, and is led by Chief Executive Officer Mark Crossley.AI Generated. May Contain Errors. Read More Receive INVVY Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Indivior and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. INVVY Stock News HeadlinesIndivior’s Triple Russell 2000 Defensive Inclusion Could Be A Game Changer For Indivior Pharmaceuticals (INDV)June 30, 2026 | uk.finance.yahoo.comIndivior's Chief Scientific Officer Sold Over 18,000 Company Shares. Should Investors Worry?June 14, 2026 | fool.comYour $29.97 book is free todayWhy Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options can give you up to 12 times the leverage of stocks — with a fraction of the capital tied up. This free guide lays it all out in plain English — from A to Z, with step-by-step examples you can follow in your own account.September 15 at 1:00 AM | Profits Run (Ad)Wall Street analysts predict a 27.76% upside in Indivior Pharmaceuticals Inc. (INDV): Here's what you should knowMay 5, 2026 | msn.comIndivior Pharmaceuticals Inc. (INDV) upgraded to strong buy: Here's what you should knowMay 5, 2026 | msn.comWhat Indivior Pharmaceuticals (INDV)'s Prison Cost Model Findings Mean For ShareholdersApril 2, 2026 | finance.yahoo.comIndivior Pharmaceuticals prices upsized $450M convertible senior notesMarch 13, 2026 | msn.comIndivior stock falls after convertible notes offering announcedMarch 12, 2026 | investing.comSee More Headlines INVVY Stock Analysis - Frequently Asked Questions How have INVVY shares performed this year? Indivior's stock was trading at $21.8455 at the start of the year. Since then, INVVY stock has increased by 0.0% and is now trading at $21.8455. How do I buy shares of Indivior? Shares of INVVY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Today9/15/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolOTCMKTS:INVVY Previous SymbolNASDAQ:INVVY CIK1625297 Webwww.indivior.com Phone804-379-1090Fax804-379-1215Employees800Year Founded2014Price Target and Rating Average Price Target for Indivior$50.00 High Price Target$50.00 Low Price Target$50.00 Potential Upside/Downside+128.9%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage1 Analysts Profitability EPS (Trailing Twelve Months)N/A Trailing P/E Ratio20.81 Forward P/E Ratio17.62 P/E GrowthN/ANet IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Sales & Book Value Annual Sales$791 million Price / Sales3.81 Cash Flow$1.15 per share Price / Cash Flow18.94 Book Value$1.45 per share Price / Book15.07Miscellaneous Outstanding Shares137,880,000Free FloatN/AMarket Cap$3.01 billion OptionableNot Optionable Beta0.35 Social Links 7 Best Space Stocks to Own in 2026The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.Get This Free Report This page (OTCMKTS:INVVY) was last updated on 9/15/2026 by MarketBeat.com Staff. From Our PartnersALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...Weiss Ratings | SponsoredThey didn't warn anyone in 1971. This time someone is warning you.On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...Reagan Gold Group | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredThe end may be near for these iconic stocksMarc Chaikin, founder of Chaikin Analytics, says two forces - AI disruption and fracturing global trade - are ...Chaikin Analytics | SponsoredLouis Navellier: My #1 AI stock for 2026 (name & ticker inside)Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...InvestorPlace | SponsoredReady to give options a try? Your first trade (Ticker included) -INSIDETired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...Base Camp Trading | SponsoredHere’s the stock symbol I’ve promisedWhitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...Stansberry Research | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Indivior PLC Please log in to your account or sign up in order to add this asset to your watchlist. Share Indivior With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INVVY Stock Alerts